Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
60.50
+2.30 (3.95%)
At close: Feb 10, 2026
23.47% (1Y)
| Market Cap | 6.50B +30.1% |
| Revenue (ttm) | 9.52B +28.6% |
| Net Income | 537.75M +28.4% |
| EPS | 4.99 +27.6% |
| Shares Out | 107.42M |
| PE Ratio | 12.13 |
| Forward PE | n/a |
| Dividend | 1.40 (2.31%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 1,250,965 |
| Average Volume | 696,496 |
| Open | 58.60 |
| Previous Close | 58.20 |
| Day's Range | 58.60 - 61.80 |
| 52-Week Range | 45.50 - 65.80 |
| Beta | -0.08 |
| RSI | 70.81 |
| Earnings Date | Jan 28, 2026 |